Patent · US Active

Conjugates comprising an GLP-1/glucagon dual agonist, a linker and hyaluronic acid

US10792367B2 · kind B2 · utility

1Cited by

1References

36Claims

0Family size

Assignee

Sanofi · FR

Inventors

Dieter Kadereit · Kelkheim, DE
Michael Wagner · Frankfurt am Main, DE
Thomas Olpp · Frankfurt am Main, DE
Nino Meyer · Frankfurt am Main, DE
Martin Bossart · Frankfurt am Main, DE
Andreas Evers · Frankfurt am Main, DE
Peyman Sakhaii · Frankfurt am Main, DE
Pradeep K. Dhal · Westford, US
Paul A. Konowicz · Farnham, GB
James Stefano · Bound Brook, US
Nils Poth · Frankfurt am Main, DE

Key dates

Filing date	Dec 1, 2017
Grant date	Oct 6, 2020
Priority date	—
Expiry date	Dec 1, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/605
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a conjugate or a pharmaceutically acceptable salt thereof comprising an GLP-1/Glucagon receptor agonist, a linker and a hyaluronic acid hydrogel bearing -L1-L2-L-Y—R20 groups, wherein Y represents an GLP-1/Glucagon receptor agonist moiety; and -L is a linker moiety—by formula (Ia),

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.